The MAQ™, like the initial PATES™ product the Patent/Technology Analysis Summary Sheet (PASS™), accomplishes two goals: 1) determine the commercial viability of the IP, and 2) maximize the return to the IP owner. Both products are delivered within 30 days or less. A quick triage assessment of an intellectual property (IP), the MAQ™ offers the IP owner a quad chart deliverable focused on commercial viability analysis, recommended next steps, and an overall objective score. With this initial iteration of due diligence, the IP owner can quickly understand its IP’s commercial potential.
David Chen, Director of Translational Research at the School of Medicine and Director of Coulter Translational Research Partnership, Biomedical Engineering, noted that: “SHINE Systems’ analysis, demonstrating expertise in cell-based products for regenerative medicine, offered critical commercialization insights to assist with our rigorous funding decision model.”
“The MAQ™ offers IP owners a low-cost decision tool to triage their IP, identify those likely to succeed in the marketplace, and focus the critical issues toward a successful launch”, said SHINE President Jeff Thomas.
About SHINE
SHINE Systems & Technologies (SHINE; www.shinesystech.com) is an engineering, solutions, and innovation firm headquartered in Charlottesville, VA. SHINE Systems is focused on enabling clients with end-to-end solutions that leverage workflow, technology integration, collaboration, and innovation. Our client base includes the Federal Government, State and Local Governments, Non-Profits, and Commercial firms. SHINE Systems’ subject matter expertise encompasses military and business Intelligence Analysis, Fusion, and Analytics; web and non-web based Software Engineering; Business Process and Workflow Engineering, Re-Engineering, and Optimization; Collaboration and Strategic Planning; the Information Technologies; the Health and Life Sciences; and Intellectual Property management and commercialization.